AI Article Synopsis
- The study explores how the multidrug transporter P-glycoprotein (P-gp) contributes to cancer drug resistance, focusing on the binding sites for morphine and nicardipine.
- Molecular dynamics simulations reveal that these drugs interact with similar key residues in the P-gp, highlighting that their binding sites are not distinctly separate.
- The findings emphasize the complexity of P-gp's drug binding and transport mechanisms, suggesting that understanding these interactions is crucial for improving drug delivery in cancer treatment.
Article Abstract
The multidrug transporter P-glycoprotein (P-gp) is central to the development of multidrug resistance in cancer. While residues essential for transport and binding have been identified, the location, composition, and specificity of potential drug binding sites are uncertain. Here molecular dynamics simulations are used to calculate the free energy profile for the binding of morphine and nicardipine to P-gp. We show that morphine and nicardipine primarily interact with key residues implicated in binding and transport from mutational studies, binding at different but overlapping sites within the transmembrane pore. Their permeation pathways were distinct but involved overlapping sets of residues. The results indicate that the binding location and permeation pathways of morphine and nicardipine are not well separated and cannot be considered as unique. This has important implications for our understanding of substrate uptake and transport by P-gp. Our results are independent of the choice of starting structure and consistent with a range of experimental studies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/ci5007382 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Combination Therapy With Nicardipine and Isosorbide Dinitrate to Prevent Spasm in Transradial Percutaneous Coronary Intervention (from the NISTRA Multicenter Double-Blind Randomized Controlled Trial).
Am J Cardiol
February 2023
Cardiology A Department, University of Monastir, Research Laboratory LR12 SP 16, Fattouma Bourguiba University Hospital, Rue du 1er juin, Monastir, Tunisia.
Verapamil and nitroglycerin are widely used to prevent radial artery spasm (RAS) during percutaneous cardiovascular procedures. However, these agents are not typically available in most African countries and consequently, isosorbide dinitrate is often the only spasmolytic treatment. Our aim was to compare the efficacy of isosorbide dinitrate alone versus isosorbide dinitrate used together with nicardipine to prevent RAS during transradial coronary procedures.
View Article and Find Full Text PDFProbing the Pharmacological Binding Sites of P-Glycoprotein Using Umbrella Sampling Simulations.
J Chem Inf Model
May 2019
School of Chemistry and Molecular Biosciences (SCMB) , University of Queensland, Brisbane , QLD 4072 , Australia.
The human multidrug transporter P-glycoprotein (P-gp) transports over 200 chemically diverse substrates, influencing their bioavailability and tissue distribution. Pharmacological studies have identified both competitive and noncompetitive P-gp substrates, but neither the precise location of the substrate binding sites, nor the basis of competitive and noncompetitive interactions has been fully characterized. Here, potential of mean force (PMF) calculations are used to identify the transport-competent minimum free energy binding locations of five compounds, Hoechst 33342, Rhodamine 123, paclitaxel, tariquidar, and verapamil to P-gp.
View Article and Find Full Text PDFIdentification of Possible Binding Sites for Morphine and Nicardipine on the Multidrug Transporter P-Glycoprotein Using Umbrella Sampling Techniques.
J Chem Inf Model
June 2015
†School of Chemistry and Molecular Biosciences, §The Institute for Molecular Biosciences, and ‡School of Mathematics and Physics, University of Queensland, Brisbane, QLD 4072, Australia.
Article Synopsis
- The study explores how the multidrug transporter P-glycoprotein (P-gp) contributes to cancer drug resistance, focusing on the binding sites for morphine and nicardipine.
- Molecular dynamics simulations reveal that these drugs interact with similar key residues in the P-gp, highlighting that their binding sites are not distinctly separate.
- The findings emphasize the complexity of P-gp's drug binding and transport mechanisms, suggesting that understanding these interactions is crucial for improving drug delivery in cancer treatment.
Stability and compatibility of vancomycin for administration by continuous infusion.
J Antimicrob Chemother
May 2013
Pharmacologie cellulaire et moléculaire et Centre de pharmacie clinique, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
Background: Vancomycin is increasingly used by continuous infusion, but few specific data are available about stability under practical conditions of preparation and use, and compatibility with other intravenous drugs commonly used in the routine hospital setting.
Methods: Vancomycin stability [defined as recovery ≥ 93% of the original content (validated HPLC assay)] was examined throughout the whole process of centralized preparation, storage and use in the ward by infusion for up to 48 h, with allowances for deviations from recommended practice [exposure to high temperature; use of concentrated solutions (up to 83 g/L)]. Compatibility was assessed by mimicking co-administration in a single line via Y-shaped connectors with contact of 1 h at 25°C, followed by visual inspection (professional viewer), detection of particulate matter (particle analyser) and HPLC assay of vancomycin.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!